• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    Tezacaftor
    |
    Weekly News Recap #Phispers Tezacaftor
    Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot

    Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot

    This week’s Phispers is a double bill with news from the last two weeks. Through much of December, the US Food and Drug A...

    Impressions : 1462

    Global drug sales to hit US$ 1.2 trillion by 2024; Gates launches biotech startup

    This week in Phispers, we bring you the world drug forecasts and trends from Evaluate Pharma. There is news from Novo Nordisk a...

    Impressions : 3299

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.